iShares Biotechnology ETF Holdings
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 5639.65m in AUM and 249 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
Last Updated: 6 days, 22 hours ago
Last reported holdings - iShares Biotechnology ETF
Ticker | Name | Est. Value |
---|---|---|
GILD
|
GILEAD SCIENCES INC | $403.9 million |
AMGN
|
AMGEN INC | $391.5 million |
REGN
|
REGENERON PHARMACEUTICALS INC | $364.2 million |
VRTX
|
VERTEX PHARMACEUTICALS INC | $350.4 million |
ALNY
|
ALNYLAM PHARMACEUTICALS INC | $340.5 million |
IQV
|
IQVIA HOLDINGS INC | $195.5 million |
ARGX
|
ARGENX SE ADR | $163.7 million |
MTD
|
METTLER TOLEDO INC | $160.3 million |
INSM
|
INSMED INC | $145.0 million |
NTRA
|
NATERA INC | $131.1 million |
BIIB
|
BIOGEN INC | $117.2 million |
WAT
|
WATERS CORP | $106.7 million |
ONC
|
BEONE MEDICINES AG | $100.4 million |
INCY
|
INCYTE CORP | $96.4 million |
BNTX
|
BIONTECH SE ADR | $92.2 million |
ILMN
|
ILLUMINA INC | $92.0 million |
UTHR
|
UNITED THERAPEUTICS CORP | $81.6 million |
NBIX
|
NEUROCRINE BIOSCIENCES INC | $80.1 million |
MEDP
|
MEDPACE HOLDINGS INC | $66.6 million |
BMRN
|
BIOMARIN PHARMACEUTICAL INC | $65.8 million |
GMAB
|
GENMAB SPONSORED ADR | $61.5 million |
EXEL
|
EXELIXIS INC | $60.4 million |
HALO
|
HALOZYME THERAPEUTICS INC | $53.6 million |
MDGL
|
MADRIGAL PHARMACEUTICALS INC | $53.0 million |
BBIO
|
BRIDGEBIO PHARMA INC | $51.0 million |
TECH
|
BIO TECHNE CORP | $50.8 million |
MRNA
|
MODERNA INC | $50.6 million |
CRL
|
CHARLES RIVER LABORATORIES INTERNA | $47.9 million |
ASND
|
ASCENDIS PHARMA ADR REPRESENTING | $44.8 million |
TEM
|
TEMPUS AI INC CLASS A | $40.7 million |
IONS
|
IONIS PHARMACEUTICALS INC | $40.0 million |
RGEN
|
REPLIGEN CORP | $39.2 million |
RVMD
|
REVOLUTION MEDICINES INC | $37.5 million |
RYTM
|
RHYTHM PHARMACEUTICALS INC | $36.6 million |
RNA
|
AVIDITY BIOSCIENCES INC | $32.2 million |
VRNA
|
VERONA PHARMA ADR PLC | $31.0 million |
ROIV
|
ROIVANT SCIENCES LTD | $30.1 million |
AXSM
|
AXSOME THERAPEUTICS INC | $29.7 million |
ALKS
|
ALKERMES | $28.2 million |
CRSP
|
CRISPR THERAPEUTICS AG | $26.5 million |
CYTK
|
CYTOKINETICS INC | $26.3 million |
ACAD
|
ACADIA PHARMACEUTICALS INC | $26.3 million |
MRUS
|
MERUS NV | $24.6 million |
ADMA
|
ADMA BIOLOGICS INC | $24.2 million |
LEGN
|
LEGEND BIOTECH ADR REP CORP | $23.8 million |
PCVX
|
VAXCYTE INC | $23.2 million |
PTCT
|
PTC THERAPEUTICS INC | $23.2 million |
KRYS
|
KRYSTAL BIOTECH INC | $22.6 million |
BRKR
|
BRUKER CORP | $20.8 million |
PTGX
|
PROTAGONIST THERAPEUTICS INC | $20.5 million |
NUVL
|
NUVALENT INC CLASS A | $20.4 million |
AKRO
|
AKERO THERAPEUTICS INC | $20.3 million |
MIRM
|
MIRUM PHARMACEUTICALS INC | $18.2 million |
APLS
|
APELLIS PHARMACEUTICALS INC | $17.5 million |
XENE
|
XENON PHARMACEUTICALS INC | $17.3 million |
ACLX
|
ARCELLX INC | $16.8 million |
SMMT
|
SUMMIT THERAPEUTICS INC | $16.4 million |
RARE
|
ULTRAGENYX PHARMACEUTICAL INC | $16.2 million |
CRNX
|
CRINETICS PHARMACEUTICALS INC | $16.1 million |
ARWR
|
ARROWHEAD PHARMACEUTICALS INC | $15.5 million |
SRRK
|
SCHOLAR ROCK HOLDING CORP | $14.6 million |
VCYT
|
VERACYTE INC | $14.0 million |
FOLD
|
AMICUS THERAPEUTICS INC | $13.7 million |
KYMR
|
KYMERA THERAPEUTICS INC | $13.4 million |
ZLAB
|
ZAI LABORATORY ADR REPRESENTING LT | $13.4 million |
AGIO
|
AGIOS PHARMACEUTICALS INC | $12.8 million |
TARS
|
TARSUS PHARMACEUTICALS INC | $12.7 million |
DNLI
|
DENALI THERAPEUTICS INC | $11.9 million |
IDYA
|
IDEAYA BIOSCIENCES INC | $11.9 million |
ADPT
|
ADAPTIVE BIOTECHNOLOGIES CORP | $11.6 million |
VCEL
|
VERICEL CORP | $10.8 million |
SRPT
|
SAREPTA THERAPEUTICS INC | $10.3 million |
BCRX
|
BIOCRYST PHARMACEUTICALS INC | $10.3 million |
GRFS
|
GRIFOLS ADR REPRESENTING ONE NON-V | $9.8 million |
ARQT
|
ARCUTIS BIOTHERAPEUTICS INC | $9.8 million |
XTSLA
|
BLK CSH FND TREASURY SL AGENCY | $9.8 million |
TVTX
|
TRAVERE THERAPEUTICS INC | $9.4 million |
COGT
|
COGENT BIOSCIENCES INC | $9.2 million |
RXRX
|
RECURSION PHARMACEUTICALS INC CLAS | $9.1 million |
BEAM
|
BEAM THERAPEUTICS INC | $9.1 million |
TWST
|
TWIST BIOSCIENCE CORP | $9.1 million |
NAMS
|
NEWAMSTERDAM PHARMA NV | $9.0 million |
TXG
|
10X GENOMICS INC CLASS A | $8.9 million |
DYN
|
DYNE THERAPEUTICS INC | $8.8 million |
AUPH
|
AURINIA PHARMACEUTICALS INC | $8.8 million |
BHVN
|
BIOHAVEN LTD | $8.4 million |
APGE
|
APOGEE THERAPEUTICS INC | $8.2 million |
SNDX
|
SYNDAX PHARMACEUTICALS INC | $8.1 million |
ETNB
|
89BIO INC | $8.0 million |
MNKD
|
MANNKIND CORP | $8.0 million |
MESO
|
MESOBLAST ADR REPRESENTING LTD | $7.8 million |
IRON
|
DISC MEDICINE INC | $7.6 million |
WVE
|
WAVE LIFE SCIENCES LTD | $7.4 million |
CGON
|
CG ONCOLOGY INC | $7.2 million |
NVCR
|
NOVOCURE LTD | $7.2 million |
DVAX
|
DYNAVAX TECHNOLOGIES CORP | $7.1 million |
STVN
|
STEVANATO GROUP | $7.0 million |
JANX
|
JANUX THERAPEUTICS INC | $6.9 million |
NTLA
|
INTELLIA THERAPEUTICS INC | $6.8 million |
EWTX
|
EDGEWISE THERAPEUTICS INC | $6.8 million |
NVAX
|
NOVAVAX INC | $6.8 million |
VERA
|
VERA THERAPEUTICS INC CLASS A | $6.5 million |
IMVT
|
IMMUNOVANT INC | $6.1 million |
GRAL
|
GRAIL INC | $6.1 million |
GLPG
|
GALAPAGOS ADR REPRESENTING NV | $6.1 million |
ZYME
|
ZYMEWORKS INC | $6.1 million |
IMCR
|
IMMUNOCORE HOLDINGS ADR PLC | $6.0 million |
ABCL
|
ABCELLERA BIOLOGICS INC | $5.8 million |
CRMD
|
CORMEDIX INC | $5.7 million |
LENZ
|
LENZ THERAPEUTICS INC | $5.4 million |
CNTA
|
CENTESSA PHARMACEUTICALS AMERICAN | $5.4 million |
ALVO
|
ALVOTECH SA | $5.3 million |
FTRE
|
FORTREA HOLDINGS INC | $5.3 million |
GERN
|
GERON CORP | $5.2 million |
SYRE
|
SPYRE THERAPEUTICS INC | $5.2 million |
STOK
|
STOKE THERAPEUTICS INC | $5.1 million |
PRAX
|
PRAXIS PRECISION MEDICINES INC | $5.1 million |
QURE
|
UNIQURE NV | $4.9 million |
ELVN
|
ENLIVEN THERAPEUTICS INC | $4.8 million |
AVXL
|
ANAVEX LIFE SCIENCES CORP | $4.6 million |
USD
|
USD CASH | $4.6 million |
URGN
|
UROGEN PHARMA LTD | $4.5 million |
EVO
|
EVOTEC SE SPONSORED ADR | $4.5 million |
PGEN
|
PRECIGEN INC | $4.4 million |
SPRY
|
ARS PHARMACEUTICALS INC | $4.3 million |
NRIX
|
NURIX THERAPEUTICS INC | $4.2 million |
CDNA
|
CAREDX INC | $4.1 million |
RCUS
|
ARCUS BIOSCIENCES INC | $4.1 million |
RIGL
|
RIGEL PHARMACEUTICALS INC | $4.1 million |
KURA
|
KURA ONCOLOGY INC | $4.0 million |
NUVB
|
NUVATION BIO INC CLASS A | $4.0 million |
GPCR
|
STRUCTURE THERAPEUTICS ADR INC | $4.0 million |
CSTL
|
CASTLE BIOSCIENCES INC | $4.0 million |
TBPH
|
THERAVANCE BIOPHARMA INC | $3.9 million |
MLYS
|
MINERALYS THERAPEUTICS INC | $3.7 million |
AMLX
|
AMYLYX PHARMACEUTICALS INC | $3.7 million |
IOVA
|
IOVANCE BIOTHERAPEUTICS INC | $3.7 million |
TSHA
|
TAYSHA GENE THERAPIES INC | $3.7 million |
DAWN
|
DAY ONE BIOPHARMACEUTICALS INC | $3.4 million |
MYGN
|
MYRIAD GENETICS INC | $3.3 million |
ABUS
|
ARBUTUS BIOPHARMA CORP | $3.3 million |
XNCR
|
XENCOR INC | $3.3 million |
ANAB
|
ANAPTYSBIO INC | $3.2 million |
KALV
|
KALVISTA PHARMACEUTICALS INC | $3.1 million |
KROS
|
KEROS THERAPEUTICS INC | $3.1 million |
5CV.DE
|
CUREVAC NV | $3.1 million |
ZVRA
|
ZEVRA THERAPEUTICS INC | $3.0 million |
OPK
|
OPKO HEALTH INC | $3.0 million |
TRVI
|
TREVI THERAPEUTICS INC | $3.0 million |
ARVN
|
ARVINAS INC | $3.0 million |
ORIC
|
ORIC PHARMACEUTICALS INC | $2.9 million |
RLAY
|
RELAY THERAPEUTICS INC | $2.9 million |
CTKB
|
CYTEK BIOSCIENCES INC | $2.9 million |
TERN
|
TERNS PHARMACEUTICALS INC | $2.9 million |
ORKA
|
ORUKA THERAPEUTICS INC | $2.9 million |
LAB
|
STANDARD BIOTOOLS INC | $2.9 million |
PHAT
|
PHATHOM PHARMACEUTICALS INC | $2.8 million |
VIR
|
VIR BIOTECHNOLOGY INC | $2.7 million |
DNA
|
GINKGO BIOWORKS HOLDINGS INC CLASS | $2.7 million |
EBS
|
EMERGENT BIOSOLUTIONS INC | $2.6 million |
FLGT
|
FULGENT GENETICS INC | $2.6 million |
ARCT
|
ARCTURUS THERAPEUTICS HOLDINGS INC | $2.6 million |
RGNX
|
REGENXBIO INC | $2.5 million |
MGTX
|
MEIRAGTX HOLDINGS PLC | $2.5 million |
TNGX
|
TANGO THERAPEUTICS INC | $2.5 million |
TYRA
|
TYRA BIOSCIENCES INC | $2.4 million |
SANA
|
SANA BIOTECHNOLOGY INC | $2.3 million |
AVBP
|
ARRIVENT BIOPHARMA INC | $2.3 million |
TRML
|
TOURMALINE BIO INC | $2.2 million |
PACB
|
PACIFIC BIOSCIENCES OF CALIFORNIA | $2.1 million |
PRTA
|
PROTHENA PLC | $2.1 million |
REPL
|
REPLIMUNE GROUP INC | $2.0 million |
RCKT
|
ROCKET PHARMACEUTICALS INC | $2.0 million |
SLDB
|
SOLID BIOSCIENCES INC | $1.9 million |
ALMS
|
ALUMIS INC | $1.9 million |
ALT
|
ALTIMMUNE INC | $1.8 million |
YMAB
|
Y MABS THERAPEUTICS INC | $1.8 million |
ATXS
|
ASTRIA THERAPEUTICS INC | $1.8 million |
AURA
|
AURA BIOSCIENCES INC | $1.8 million |
RAPP
|
RAPPORT THERAPEUTICS INC | $1.8 million |
OLMA
|
OLEMA PHARMACEUTICALS INC | $1.7 million |
CRVS
|
CORVUS PHARMACEUTICALS INC | $1.7 million |
INBX
|
INHIBRX BIOSCIENCES INC | $1.7 million |
ABSI
|
ABSCI CORP | $1.6 million |
TECX
|
TECTONIC THERAPEUTIC INC | $1.6 million |
CGEM
|
CULLINAN THERAPEUTICS INC | $1.6 million |
VNDA
|
VANDA PHARMACEUTICALS INC | $1.6 million |
CMPS
|
COMPASS PATHWAYS ADR PLC | $1.5 million |
FDMT
|
4D MOLECULAR THERAPEUTICS INC | $1.5 million |
SVRA
|
SAVARA INC | $1.5 million |
ERAS
|
ERASCA INC | $1.5 million |
MRVI
|
MARAVAI LIFESCIENCES HOLDINGS INC | $1.5 million |
ADCT
|
ADC THERAPEUTICS SA | $1.5 million |
PSNL
|
PERSONALIS INC | $1.5 million |
AVIR
|
ATEA PHARMACEUTICALS INC | $1.5 million |
AUTL
|
AUTOLUS THERAPEUTICS ADR PLC | $1.4 million |
NGNE
|
NEUROGENE INC | $1.3 million |
GLUE
|
MONTE ROSA THERAPEUTICS INC | $1.3 million |
EDIT
|
EDITAS MEDICINE INC | $1.3 million |
CDXS
|
CODEXIS INC | $1.3 million |
IBRX
|
IMMUNITYBIO INC | $1.3 million |
IRWD
|
IRONWOOD PHARMA INC CLASS A | $1.3 million |
ANNX
|
ANNEXON INC | $1.2 million |
HUMA
|
HUMACYTE INC | $1.2 million |
BCYC
|
BICYCLE THERAPEUTICS ADR PLC | $1.1 million |
CATX
|
PERSPECTIVE THERAPEUTICS INC | $1.1 million |
QTRX
|
QUANTERIX CORP | $1.1 million |
ALEC
|
ALECTOR INC | $1.1 million |
PRME
|
PRIME MEDICINE INC | $1.1 million |
ALLO
|
ALLOGENE THERAPEUTICS INC | $1.1 million |
ENTA
|
ENANTA PHARMACEUTICALS INC | $1.0 million |
DSGN
|
DESIGN THERAPEUTICS INC | $1.0 million |
IMMP
|
IMMUTEP ADS REPRESENTING LTD | $961140 |
VYGR
|
VOYAGER THERAPEUTICS INC | $920026 |
CYBN
|
CYBIN INC | $907204 |
LRMR
|
LARIMAR THERAPEUTICS INC | $876457 |
SGAFT
|
CASH COLLATERAL USD SGAFT | $868000 |
FHTX
|
FOGHORN THERAPEUTICS INC | $860733 |
CCCC
|
C4 THERAPEUTICS INC | $836050 |
CLYM
|
CLIMB BIO INC | $820554 |
MXCT
|
MAXCYTE INC | $811083 |
ACIU
|
AC IMMUNE SA | $764768 |
TRDA
|
ENTRADA THERAPEUTICS INC | $755399 |
SLN
|
SILENCE THERAPEUTICS ADR REPRESENT | $722766 |
NMRA
|
NEUMORA THERAPEUTICS INC | $699957 |
LXEO
|
LEXEO THERAPEUTICS INC | $689490 |
FATE
|
FATE THERAPEUTICS INC | $689124 |
NKTX
|
NKARTA INC | $683799 |
MGNX
|
MACROGENICS INC | $577505 |
BMEA
|
BIOMEA FUSION INC | $572547 |
PLRX
|
PLIANT THERAPEUTICS INC | $524037 |
RNAC
|
CARTESIAN THERAPEUTICS INC | $507019 |
TCRX
|
TSCAN THERAPEUTICS INC | $481914 |
KYTX
|
KYVERNA THERAPEUTICS INC | $464335 |
STRO
|
SUTRO BIOPHARMA INC | $421873 |
LYEL
|
LYELL IMMUNOPHARMA INC | $390819 |
APLT
|
APPLIED THERAPEUTICS INC | $378109 |
PYXS
|
PYXIS ONCOLOGY INC | $364946 |
TKNO
|
ALPHA TEKNOVA INC | $285994 |
PEPG
|
PEPGEN INC | $210833 |
ARTV
|
ARTIVA BIOTHERAPEUTICS INC | $209991 |
MRSN
|
MERSANA THERAPEUTICS INC | $184820 |
ACRV
|
ACRIVON THERAPEUTICS INC | $168846 |
TVGN
|
TEVOGEN BIO HOLDINGS INC | $154293 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | $145355 |
ADRO
|
CHINOOK THERAPEUTICS INC | $54563 |
QTTB
|
Q32 BIO INC | $43198 |
CRGX
|
CARGO THERAPEUTICS INC | $21117 |
THRD
|
THIRD HARMONIC BIO INC | $4034 |
-
|
CARTESIAN THERAPEUTICS INC | $1874 |
-
|
FUSION PHARMACEUTICALS INC CVR | $1034 |
-
|
AKOUOS CVRS Prvt | $1 |
-
|
OMNIAB INC $15.00 VESTING Prvt | $0 |
-
|
OMNIAB INC $12.50 VESTING Prvt | $0 |
RTYU5
|
RUSSELL 2000 EMINI CME SEP 25 | $0 |
IXCU5
|
E-MINI HEALTH CARE SECTOR SEP 25 | $0 |
Recent Changes - iShares Biotechnology ETF
Date | Ticker | Name | Change (Shares) |
---|---|---|---|
2025-08-28 |
ITOS
|
ITEOS THERAPEUTICS INC | -223,616 |
2025-08-28 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,128 |
2025-08-28 |
LYEL
|
LYELL IMMUNOPHARMA INC | 35,209 |
2025-08-28 |
LYEL
|
LYELL IMMUNOPHARMA INC | -35,561 |
2025-08-28 |
MRSN
|
MERSANA THERAPEUTICS INC | -24,368 |
2025-08-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-27 |
LYEL
|
LYELL IMMUNOPHARMA INC | 35,561 |
2025-08-27 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -35,869 |
2025-08-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-27 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,368 |
2025-08-27 |
MRSN
|
Mersana Therapeutics Inc | -24,578 |
2025-08-27 |
CRGX
|
Cargo Therapeutics Inc | -198,104 |
2025-08-26 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,578 |
2025-08-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-26 |
MRSN
|
Mersana Therapeutics Inc | -24,578 |
2025-08-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-26 |
CRGX
|
Cargo Therapeutics Inc | -198,104 |
2025-08-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-25 |
CRGX
|
Cargo Therapeutics Inc | -198,104 |
2025-08-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-20 |
CRGX
|
CARGO THERAPEUTICS INC | -198,104 |
2025-08-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-08-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-08-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-14 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 536,000 |
2025-08-13 |
IGMS
|
IGM BIOSCIENCES INC | -94,726 |
2025-08-12 |
MRSN
|
Mersana Therapeutics Inc | -24,998 |
2025-08-12 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,428 |
2025-08-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-11 |
MRSN
|
Mersana Therapeutics Inc | -25,058 |
2025-08-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-11 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,998 |
2025-08-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-08 |
MRSN
|
Mersana Therapeutics Inc | 25,058 |
2025-08-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-08-08 |
MRSN
|
MERSANA THERAPEUTICS INC | -24,608 |
2025-08-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-08-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-08-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-08-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-08-01 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,638 |
2025-08-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-08-01 |
MRSN
|
Mersana Therapeutics Inc | -24,638 |
2025-07-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-30 |
SAGE
|
SAGE THERAPEUTICS INC | -340,518 |
2025-07-29 |
MRSN
|
Mersana Therapeutics Inc | -24,668 |
2025-07-29 |
MRSN
|
MERSANA THERAPEUTICS INC | 24,608 |
2025-07-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-07-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-07-24 |
VERV
|
VERVE THERAPEUTICS INC | -406,973 |
2025-07-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-07-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-07-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-16 |
BPMC
|
BLUEPRINT MEDICINES CORP | -376,137 |
2025-07-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-07-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-07-02 |
SWTX
|
SPRINGWORKS THERAPEUTICS INC | -455,747 |
2025-07-01 |
INZY
|
INOZYME PHARMA INC | -270,993 |
2025-06-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-06-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-06-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-06-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-06-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-06-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-06-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-06-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-06-02 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -734,993 |
2025-06-02 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | 36,749 |
2025-05-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-05-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-05-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-05-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-05-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-21 |
SLRN
|
ACELYRIN INC | -449,982 |
2025-05-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-05-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-05-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-13 |
TSVT
|
2SEVENTY BIO INC | -288,191 |
2025-05-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-05-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-05-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-05-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-05-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-04-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-04-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-04-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-04-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-04-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-04-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-04-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-04-03 |
ITCI
|
INTRA CELLULAR THERAPIES INC | -632,015 |
2025-04-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-04-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-04-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-03-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-03-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-03-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
2025-03-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
2025-03-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-03-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-03-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-03-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-03-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
2025-03-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
2025-03-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |